INTRODUCTION
The calcification of polymeric materials in long-term medical implants such is cardiac assist devices and artificial hearts is increasingly being recognized. Calcification is a complex phenomenon governed by biochemical, physiological, physico-chemical and species-related factors.
This brief editorial review will try to summarize what is known about this serious problem. DISCUSSION 
Biochemical Origins of calcification
Biochemical explanations of calcification implicate vitamin K in blood clotting and the special Ca 2+ binding amino acid, y-carboxyglutamic acid. Vitamin K-dependent plasma proteins and blood clotting factors containing y-carboxyglutamic acid include atherocalcin, osteocalcin, protein C, prothrombin (factor II), factors IX and X. The bioconversion of the glutamate residue in precursor prothrombin (descarboxyprothrombin) to calcium binding y-carboxyglutamate residue in prothrombin takes place under the influence of a vitamin K-requiring enzyme system (1) .
Another vitamin K-dependent agent is protein C. It inhibits coagulation by inactivating factors V and VIII, and, at least in dogs, promotes fibrinolysis (2) . Recently questions were raised about the fibrinolytic activity of The International Journal Of Artificial Organs 1 Vol. 8 no. 2, 19851 p.p. 65-68 protein C in humans. This is based on work done with squirrel monkeys indicating that in this primate no increase of fibrinolytic activity was observed by the administration of activated human protein C or upon the activation of endogenous protein C (3) .
Human protein C has a molecular weight of 62,000 and contains two chains linked by disulfide bonds: a heavy chain (molecular weight 41,000), and a light chain (molecular weight 21,000).
The light chain contains y-carboxyglutamic acid residues involved in Ca 2+-dependent membrane association (2) .
In contrast to human protein C, the light chain of bovine protein C also contains one residue of erythro-f3hydroxyaspartic acid with as yet unknown functional importance (4).
Physiological factors: calcium homeostasis
In plasma about half of the calcium is present as free ions, the rest being largely bound to proteins, especially albumin. Phosphorus, in the forms of HP04 2and H2P04-, represents about 53% of the total in plasma. An additional 12% is protein bound, 29% is in the form of NaHP04- (5) . The main regulating agents are calcitonin (produced by the «C» cells of ultimo branchial cells of the thyroid), parathormone, and vitamin D. The exchange of calcium between plasma and bone continues even in the absence of endocrine influences but serum calcium is lowered. Calcium and phosphorus occur in bone mostly as hydroxyapatite [(Ca3P04)2)sCa(OH)2. Obsteoblasts, that synthesize collagen, and osteocytes, that take part in osteolysis, are the main cells responsible for new bone production.
Of some 1,200 g calcium in bone, less than 1% exchanges freely with extracellular calcium, normally at a rate of about 2 glday (5). Various stimuli can cause a rapid readjustment of extracellular calcium levels from the bone. The concentrations of calcium and phosphate also influence bone accretion and resorption. Vitamin D facilitates the absorption of calcium and the calcification of bone. Its main effect is to raise the serum calcium concentration.
The kidney and the bones are the two main sites of action for the parathyroid hormone, through cyclic AMP. Parathormone prevents renal tubular reabsorption of phosphate. When plasma phosphate concentration is low, phosphate is released from the bone and calcium is released into the blood by the degradation of hydroxyapatite. If the plasma phosphate concentration is high, bone accretion occurs and the plasma calcium concentration is lowered. Other factor affect bone resorption and accretion, such as the pH of the mineral environment.
Physico-chemical factors
Calcification is not unique to any particular material. It has been observed with glutaraldehyde-treated tissue valves (xenografts) and with polymers of diverse chemical structures (6) .
Growing children as well as calves are particularly predisposed to calcify implanted, blood contacting bioprostheses. The calcification of xenografts has been attributed to calcium homeostasis (7) and warfarin has been claimed to reduce the calcification in calves of segmented polyether-urethanes (8) .
Yet this may have been an isolated observation, because others have reported calcification with polyurethanes, silicone, and other polymers despite giving warfarin.
As both warfarin and coumadin are vitamin K antagonists, it is not clear why the reported suppression of calcification with the particular polyurethane elastomer was not also observed with other polymers, if indeed the postulated vitamin K-dependent protein carboxylation process were to be the only decisive factor. Consequently, other mechanisms are also involved in the calcification process.
Although calcification is not restricted to flexing materials, it is nevertheless observed to take place in experimental cardiac assist devices and artificial hearts primarily at the flexing areas of pumps. For xenoqrafts it has been proposed that removing the outside protective layer of proteoglycan during the processing of porcine valves uncovers the epsilon-amino groups in lysine and hydroxylysine, thus allowing the formation of bonds between the native collagen and phosphate groups (9) . Furthermore, the loss of proteoglycan opens the collagen structure to the penetration of plasma proteins and other blood constituents, thus providing additional loci for calcification (9) .
Thrombi formed on the surfaces can also calcify and cause calcific deposits in distant organs. Also, the crosslinks formed with glutaraldehyde are more complex than commonly depicted, especially with respect to length and unsaturated linkages, and variations in cross links likely influence the long-term performance of xenog rafts (10) .
Surfactant (sodium dodecyl sulfate and isopropanol) treated procine xenograft tricuspid valves showed somewhat less severe calcification in young sheep over a period of 20 weeks, but little difference or even increased calcification was observed with similarly treated bovine pericardial valves (11) .
In earlier publications (6, 12) I proposed that absorption and permeation (in addition to surface adsorption) of plasma components by polymeric materials in contact with blood may be important in calcification, in addition to biochemical and physiological factors. This prediction was validated by the recent finding of calcium deposits, not only on the surfaces of polyurethane blood pump diaphragms of artificial hearts, but also deep inside the polymeric diaphragms (13, 14) .
Occasionally, among a large number of experimental animals (mostly calves) there are some in which calcification of identically prepared prostheses in minimal (13) .
This may, however, be associated with the relative health of the animals. Just as some people are less prone to atherosclerosis, so one could expect a similar pattern in experimental animals.
Unfortunately appropriate studies are lacking. It may therefore be unrealistic to point to a few statistically insignificant marathon experiments that have led to premature expectations in man.
As I noted elsewhere (12) , repeated flexing and other so-called «macroscopic deformation» of elastomers may cause microscopic deformations of their structural elements, giving rise to «opening» and «closing» of pores. This may then allow the entry by absorption and penetration of blood components or drugs, depending on factors such as thermodynamic parameters, domain structures, surface defects, and porosity. These factors in turn are functions of the molecular and supramolecular structures of the polymer system. To achieve optimum and reproducible properties of a given polymer system is a formidable task and poses special problems with biomaterialso It should be noted that the ultra-smooth, dense, pyrolitic carbon used in many mechanical heart valves does not calcify. Should calcification occur, it is restricted to the fabric covering of sewing rings. The lack of calcification of this carbon may be due not only to its good blood compatibility and thromboresistance (12) but also to its impermeability to blood components and administered drugs.
We have recently shown that poly(dimethyl siloxane) [Silastic'"], and polyether-urethane/poly(dimethyl siloxane) copolymer [Avcothane'", Cardiothanew] are permeable to various drugs (15) (16) (17) . Inasmuch as large quantities of various drugs are usually given during cardiac implantation survery, these drugs and the plasma components could find their way inside the polymeric materials of the prostheses and serve as loci for calcification (17) . Once calcification begins, it will eventually cause cracks and weaken the polymer. This in turn will promote further calcification and thrombosis, not only within the polymer but also in distant organs.
CONCLUSION
During the past 30 years, the emphasis on surface phenomena in biomaterials research has given rise to some dogmatic views. Yet recent findings (13, 14) and ongoing animal work with proprietary materials clearly indicate the contribution of my previously predicted absorption and permeation phenomena (6) (in addition to biochemical and surface characteristics) in the calcification of polymeric components of flexing implanted devices. While perhaps this process could be slowed. I doubt that it can be entirely prevented, considering our meager understanding of calcification, both in natural tissues and synthetic materials. For this and other reasons, the enthusiasm for long-term clinical use of totally implantable, ambulatory ventricular assist devices, artificial hearts, and associated devices must be tempered with reality. In the foreseeable future simpler cardiac devices that do not require implantation may constitute a more realistic approach for short interim periods. 
